niraparibum 50 mg ut niraparibi tosilas monohydricus 79.7 mg, abirateroni acetas 500 mg corresp. abirateronum 446 mg, hypromellosum, natrii laurilsulfas, lactosum 240.54 mg ut lactosum monohydricum, crospovidonum, cellulosum microcristallinum silicificatum, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), E 171, glyceroli monocaprylocapras, talcum, natrii laurilsulfas, E 172 (flavum), E 172 (rubrum), E 172 (nigrum), pro compresso obducto corresp. natrium 5.05 mg.
Packungsbestandteile
Coated tablets
Active Agent
Dose
Abirateroni Acetas
500 mg correspond Abirateronum 446 mg
Niraparibum
50 mg
Inactive agents
Dose
additional_information
(Flavum)
(Nigrum)
(Rubrum)
Cellulosum Microcristallinum Silicificatum
Crospovidonum
E 171
color.
E 172
color.
Glyceroli Monocaprylocapras
Hypromellosum
Lactosum
240.54 mg
Magnesii Stearas
Natrii Laurilsulfas
Poly(Alcohol Vinylicus)
Überzug
Pro Compresso Obducto
Silica Colloidalis Anhydrica
Talcum
Source
Data was imported : 04.05.2024
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
